Author: Bylinskii, Y.
Paper Title Page
THB03 Conceptual Design of TR100+: An Innovative Superconducting Cyclotron for Commercial Isotopes Production 298
  • Y.-N. Rao, R.A. Baartman, Y. Bylinskii, T. Planche, L.G. Zhang
    TRIUMF, Vancouver, Canada
  Utilizing dedicated cyclotrons to produce medical isotopes is an arising technology in hospitals across Canada. Thus, in January 2015, the CycloMed99 team, led by TRIUMF, demonstrated a breakthrough in producing the world’s most highly used medical isotope, technetium-99m (Tc-99m), on existing medical cyclotrons. Now we propose to design an innovative superconducting cyclotron for production of commercially valuable radioisotopes. This project will be focusing on a proton energy of 70-150 MeV and proton current of 2 mA. In this energy range, numerous increasingly demanded radio­nuclides can be produced, either as parent nuclei for generator use, or directly as a active pharmaceutical ingredient, e.g. Strontium-82 (Sr-82), Actinium-235 (Ac-235) and Bismuth-213 (Bi-213). Our machine shall be designed to accelerate H2+, by injection from external ion source and extraction by stripping. This shall allow to simultaneously extract multiple cw proton beams of variable currents and potentially variable energies to multiple experimental stations with extremely high extraction efficiency. The basic parameters of the machine and the simulations of stripping extraction will be presented.  
slides icon Slides THB03 [3.030 MB]  
DOI • reference for this paper ※  
About • paper received ※ 17 September 2019       paper accepted ※ 25 September 2019       issue date ※ 20 June 2020  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)